An 83-Year-Old Man with Biochemically Recurrent Metastatic Castration-Sensitive Prostate Cancer - Episode 2

First-Line Therapy Options for mCSPC

Dr Tejwani lists the frontline treatment options currently available for mCSPC and reviews the chosen treatment regimen in the presented patient case.